Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact Us

Press Releases

11.10.2021
Iveric Bio to Participate in the Stifel 2021 Virtual Healthcare Conference
11.09.2021
Iveric Bio Reports Third Quarter 2021 Operational Highlights and Financial Results
11.03.2021
Iveric Bio to Participate in the Credit Suisse 30th Annual Virtual Healthcare Conference
11.02.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11.02.2021
Iveric Bio to Report Third Quarter 2021 Financial Results and Host Conference Call on Tuesday, November 9, 2021
10.21.2021
Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock
10.21.2021
Iveric Bio Announces Proposed Offering of Common Stock
10.04.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09.10.2021
Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09.02.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap